Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma-Reference-Cited by-同舟云学术

Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma

Published:2010-08-18 Issue:5 Volume:150 Page:565-573
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

D’Amore Francesco,Radford John,Relander Thomas,Jerkeman Mats,Tilly Hervé,Österborg Anders,Morschhauser Franck,Gramatzki Martin,Dreyling Martin,Bang Bo,Hagberg Hans

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2010.08298.x/fullpdf

Reference41 articles.

1. Epidemiology of the non-Hodgkin’s lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin’s Lymphoma Classification Project;Anderson;Annals of Oncology,1998

2. Phase I/II study of an anti-CD30 monoclonal antibody (MDX-060) in Hodgkin’s lymphoma and anaplastic large-cell lymphoma;Ansell;Journal of Clinical Oncology,2007

3. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes;Armitage;Journal of Clinical Oncology,2008

4. Flow cytometric features of angioimmunoblastic T-cell lymphoma;Chen;Cytometry Part B: Clinical Cytometry,2006

5. Report of an international workshop to standardize response criteria for non-Hodgkin’s lymphomas. NCI Sponsored International Working Group;Cheson;Journal of Clinical Oncology,1999

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SOHO State of the Art Updates and Next Questions | CAR T Cells in T Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma;Clinical Lymphoma Myeloma and Leukemia;2024-05

2. Allogeneic Hematopoietic Stem Cell Transplantation for Mature T/NK-Cell Lymphomas in Children;Transplantation and Cellular Therapy;2024-04

3. Transient CD4+ T cell depletion during suppressive ART reduces the HIV reservoir in humanized mice;PLOS Pathogens;2023-12-06

4. Education and Empowering Special Forces to Eradicate Secret Defectors: Immune System-Based Treatment Approaches for Mature T- and NK-Cell Malignancies;Cancers;2023-04-28

5. The emerging scenario of immunotherapy for T-cell Acute Lymphoblastic Leukemia: advances, challenges and future perspectives;Experimental Hematology & Oncology;2023-01-09